ID   Sa3
AC   CVCL_8063
SY   Sa-3
DR   BTO; BTO:0006553
DR   CLO; CLO_0050150
DR   BioSample; SAMN03472193
DR   cancercelllines; CVCL_8063
DR   GEO; GSM850386
DR   Progenetix; CVCL_8063
DR   RCB; RCB0980
DR   Wikidata; Q54952028
RX   DOI=10.5794/jjoms.39.965;
RX   PubMed=15756446;
CC   Population: Japanese.
CC   Doubling time: 55 hours (DOI=10.5794/jjoms.39.965).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
ST   Source(s): RCB
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 9
ST   D5S818: 14
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C8173; Upper gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 17
//
RX   DOI=10.5794/jjoms.39.965;
RA   Harada M., Miyata K., Wada T., Ohmata T., Morita N., Sakamoto T.;
RT   "Establishment and characterization of a cell line (Sa3) from squamous
RT   cell carcinoma of the human gingiva.";
RL   Nihon Koku Geka Gakkai Zasshi 39:965-971(1993).
//
RX   PubMed=15756446; DOI=10.3892/or.13.4.709;
RA   Nakatani K., Nakamura M., Uzawa K., Wada T., Seki N., Tanzawa H.,
RA   Fujita S.;
RT   "Establishment and gene analysis of a cisplatin-resistant cell line,
RT   Sa-3R, derived from oral squamous cell carcinoma.";
RL   Oncol. Rep. 13:709-714(2005).
//